NCT05294653Not yet recruiting
Atherosclerotic Cardiovascular Risk in Childhood and Teen-age Onset Diabetes
Risk of Atherosclerotic Cardiovascular Disease in Childhood and Teen-age Onset Diabetes
Source: ClinicalTrials.gov · Last updated 23 May 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
For children and adolescents with diabetes, the pathological process of atherosclerotic cardiovascular disease(ASCVD) can exist in early childhood and progress rapidly to subclinical ASCVD. This study intends to explore the models for the prediction of ASCVD risk in childhood and teen-age onset diabetes with different types.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 25 Feb 2022
- Start date
- 1 Jun 2022
- Primary completion date
- 1 Jan 2027
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Diseases
- Type 1 diabetes
- NCT number
- NCT05294653
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Jun 2022 to the primary completion date, 1 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received glucocorticoids, immunosuppressants, non-glycemic biological agents, and cytotoxic drugs in the past 3 months; non-steroidal pain relievers or antibiotics used for more than 1 week continuously
- Major trauma and surgery history in the past 3 months
Other illness
- Specific types of diabetes
- Clinical diagnosis of diabetes is unknown, and it belongs to untyped diabetes
- Onset of acute complications of diabetes in the past 3 months
Other
- Pregnancy or lactation
Who the study is looking for
- Diagnosis of type 1 diabetes or type 2 diabetes
- Age of onset: \<18y
- Enrollment age: ≥18y
- Gender: male or female
- Diabetes duration ≥ 5 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Endocrinology and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.